Jun 06, 2019
BioPlus Specialty Pharmacy Dispensing Non-opioid Pain Medication Qutenza® (Capsaicin) 8% Patch in Exclusive Relationship
Nov 14, 2018
Averitas Pharma Commercializes Qutenza® in the US
Nov 14, 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Nov 13, 2018
Post Herpetic Neuralgia Treatment Market is Estimated to be Worth US$ 908.4 Mn, in Terms of Value, By 2026 - Persistence Market Research
Nov 05, 2018
Grünenthal Acquires Global Rights for Qutenza®
Nov 05, 2018
Global Post-Herpetic Neuralgia Market and Competitive Landscape 2018-2023: Develop Forecast Models, Healthcare Frameworks, & Economic Models
Sep 28, 2018
NanoViricides Inc. to Present at the MicroCap Conference in New York City on October 1
Sep 07, 2018
Scilex Presents ZTlido(TM) Data on Superior Adhesion over Lidocaine Patch Formulation
Sep 05, 2018
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th
Aug 07, 2018
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study
Jun 12, 2018
Survey Finds Less than Two-Thirds of Americans (62%) Know a Preventive Vaccine is Available for Shingles
Apr 30, 2018
NX Development Corp (NXDC) Announces Merger Acquisition by photonamic GmbH & Co. KG, a German Biotech Firm Engaged in 5-ALA-Related Pharmaceutical Business in Europe
Mar 27, 2018
Varicella Zoster Infection Treatment Market is Expected to Register a 4.2% CAGR From 2017 to 2027
Oct 25, 2017
CDC's Advisory Committee on Immunization Practices recommends Shingrix as the preferred vaccine for the prevention of shingles for adults aged 50 and up
Oct 20, 2017
FDA Approves GSK's Shingles Vaccine with Agenus' QS-21 Stimulon® Adjuvant
Oct 20, 2017
Shingrix approved in the US for prevention of shingles in adults aged 50 and over
Sep 13, 2017
FDA Advisory Committee votes unanimously for Shingrix (HZ/su) in the US for prevention of herpes zoster (shingles) in adults ages 50 and over
Aug 29, 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Jun 21, 2017
GSK presents positive results from Phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's Advisory Meeting
May 09, 2017
tesa Labtec Offers New Licensing Opportunity: Ropivacaine Transdermal Patch for the Treatment of Neuropathic Pain